Ocular (Uveal) Melanoma and Biopsy – the “Why” and “How” of It
By Timothy Fuller, MD, Ocular Oncologist With the diagnosis of ocular (uveal) melanoma comes the very real risk of metastatic disease, or “spread” of the cancer to other parts of the body.
read more Getting to Know Ocular Oncologist Timothy S. Fuller, MD
May is Ocular Melanoma Awareness Month. Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina Associates,
read more
May is Ocular Melanoma Awareness Month
Although rare, ocular (uveal) melanoma is the most common primary cancer of the eye in adults with an estimated 2,000 – 3,000 new cases in the United States each year. This type
read more Texas Retina Associates Participating in New Phase II Clinical Trial for Choroidal Melanoma
Texas Retina Associates is pleased to announce its participation in a groundbreaking new Phase II clinical trial for the treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating
read more
Ocular Melanoma and the Importance of Annual Dilated Eye Exams: Felicia Corbray’s Story
It was November 2017 when Felicia Corbray experienced the first fast, faint flash of light in her eye. A mother of three young children, including six-month old twins, she chalked it up
read more
What to Expect from a Fluorescein Angiography Test
Retina specialists use fluorescein angiography (FA) to help diagnose and monitor a number of retinal diseases and conditions, including age-related macular degeneration, diabetic retinopathy, central serous retinopathy, macular edema, macular pucker, ocular
read more